share_log

12 Health Care Stocks Moving In Monday's Intraday Session

Benzinga ·  Dec 25, 2023 12:30

Gainers

  • Jin Medical International (NASDAQ:ZJYL) shares moved upwards by 94.4% to $137.0 during Monday's regular session. The market value of their outstanding shares is at $1.0 billion.
  • Karuna Therapeutics (NASDAQ:KRTX) stock increased by 47.71% to $317.87. The market value of their outstanding shares is at $11.9 billion.
  • IMAC Hldgs (NASDAQ:BACK) shares moved upwards by 42.59% to $2.31. The market value of their outstanding shares is at $2.6 million.
  • Pasithea Therapeutics (NASDAQ:KTTA) shares rose 32.86% to $0.38. The market value of their outstanding shares is at $7.9 million.
  • PureTech Health (NASDAQ:PRTC) stock moved upwards by 31.3% to $25.0. The market value of their outstanding shares is at $679.8 million.
  • Renalytix (NASDAQ:RNLX) shares increased by 30.4% to $0.45. The company's market cap stands at $22.4 million.

Losers

  • AlloVir (NASDAQ:ALVR) stock fell 66.2% to $0.79 during Monday's regular session. The company's market cap stands at $89.7 million.
  • Cyclacel Pharmaceuticals (NASDAQ:CYCC) shares decreased by 23.89% to $2.74. The market value of their outstanding shares is at $2.3 million.
  • 60 Degrees (NASDAQ:SXTP) shares decreased by 17.28% to $0.91. The market value of their outstanding shares is at $5.2 million.
  • HOOKIPA Pharma (NASDAQ:HOOK) shares fell 16.41% to $0.72. The market value of their outstanding shares is at $60.5 million.
  • Theriva Biologics (AMEX:TOVX) shares fell 15.24% to $0.43. The company's market cap stands at $7.3 million.
  • Nanobiotix (NASDAQ:NBTX) stock declined by 14.72% to $6.55. The market value of their outstanding shares is at $308.5 million. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment